We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Bristol Myers Squibb | TG:BRM | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.049999 | 0.13% | 39.675 | 39.505 | 39.675 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 39.73 | 39.275 | 39.42 | 2,104 | 11:58:09 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 25/4/2024 | 12:53 | ALNC |  TOP NEWS: Bristol-Myers beats on revenue but swings to quarterly loss |
| 22/4/2024 | 19:44 | ALNC | Bristol-Myers inks USD380 million supply agreement with Cellares |
| 18/3/2024 | 14:22 | ALNC | IN BRIEF: BMS adds to neuroscience portfolio with Karuna acquisition |
| 02/2/2024 | 12:36 | ALNC | TOP NEWS: Bristol-Myers quarterly revenue up as new products shine |
| 02/1/2024 | 16:39 | ALNC | Bristol-Myers gets EMA validation for lung-cancer drug, repotrectinib |
| 26/12/2023 | 12:46 | ALNC | TOP NEWS: Bristol-Myers makes second holiday acquisition with RayzeBio |
| 22/12/2023 | 18:38 | ALNC | TOP NEWS: Bristol-Myers swoops for schizophrenia drugmaker Karuna |
| 11/12/2023 | 19:25 | ALNC | Leading pharmaceutical firms highlight positive trial data on lymphoma |
| 07/12/2023 | 12:39 | ALNC | Bristol-Myers Squibb to buy back extra USD3 billion shares |
| 06/12/2023 | 19:37 | ALNC | IN BRIEF: Bristol-Myers Squibb receives approval for Abecma in Japan |
1 Year Bristol Myers Squibb Chart |
Intraday Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
